Opportunistic infections in patients with pulmonary alveolar proteinosis

J Infect. 2012 Aug;65(2):173-9. doi: 10.1016/j.jinf.2012.03.020. Epub 2012 Apr 4.

Abstract

Objectives: To describe the demographics, clinical manifestations, treatment, and outcomes of patients with pulmonary alveolar proteinosis (PAP) who developed an opportunistic infection with Nocardia spp., mycobacteria or fungal pathogens.

Methods: A case of PAP and Nocardia spp. brain abscess is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of PAP and opportunistic infections between 1950 and July, 2010.

Results: Seventy five cases were reviewed. Thirty two patients (43%) had nocardial infection, 28 (37%) mycobacterial infection, and 15 (20%) fungal infection. Thirty nine patients (65%) were male. Seventeen patients (23%) were immunosuppressed. Twenty patients (27%) were active smokers. PAP was the initial diagnosis in 19 patients (33%), while infection presented first in 23 patients (40%); 16 patients (27%) had a concurrent diagnosis of PAP and infection. The average interval between PAP diagnosis and an opportunistic infection was 16 months. Lungs were the most common site of infection; extra-pulmonary infection was present in 27 patients (32%). Thirty nine patients (57%) survived through the follow-up period, while 31 died.

Conclusions: Opportunistic infections can either precede or follow a diagnosis of PAP. PAP should be considered in apparently immunocompetent patients who present with an opportunistic infection and diffuse alveolar infiltrates.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Infective Agents / administration & dosage
  • Brain / diagnostic imaging
  • Brain / pathology
  • Brain Abscess / diagnosis*
  • Brain Abscess / drug therapy
  • Brain Abscess / microbiology
  • Brain Abscess / pathology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Lung Diseases, Fungal / drug therapy
  • Lung Diseases, Fungal / epidemiology*
  • Lung Diseases, Fungal / pathology
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Mycobacterium Infections / drug therapy
  • Mycobacterium Infections / epidemiology*
  • Mycobacterium Infections / pathology
  • Nocardia Infections / diagnosis*
  • Nocardia Infections / drug therapy
  • Nocardia Infections / epidemiology*
  • Nocardia Infections / pathology
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / epidemiology*
  • Opportunistic Infections / pathology
  • Pulmonary Alveolar Proteinosis / complications*
  • Radiography, Thoracic
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Infective Agents